Trial Profile
Phase II Trial of Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Jun 2019
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Pembrolizumab (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 04 Dec 2018 Status changed from not yet recruiting to recruiting.
- 17 Sep 2018 New trial record